Sales Specialist, Uro-Oncology - New Orleans at Acadia Pharmaceuticals

New Orleans, Louisiana, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Healthcare, OncologyIndustries

Requirements

Bachelor’s degree
Minimum 4 years in buy and bill medical OR pharmaceutical sales
Strongly desired at least 2+ experience in Oncology and/or Urology
Bladder Cancer experience preferred
Able to achieve or exceed sales objectives
Able to identify potential customers and add to customer base
Able to meet expense management requirements
Able to meet demand generation goals
Physical Requirements: Sitting approximately 3 – 4 hours at a time while driving or as a

Responsibilities

Contribute to Region and Ferring success by promoting and selling Ferring products to attain or exceed established sales quotas
Regular contact with present and prospective customers
Prepare and submit timely and accurate reports to management and other Ferring stakeholders as required
Participate in Sales field rides; follow through on developmental opportunities based on results
Identify and pursue new business opportunities
Effectively deploy and pull through territory resources including marketing materials, programs, and other available and approved sales tools
Create, own and develop effective relationships with approved and targeted customers
Monitor and manage district expenses, budgets and sample allotments
Represent Ferring at appropriate professional industry meetings and seminars

Skills

Pharmaceutical Sales

Territory Management

Product Promotion

Healthcare Professionals

Wholesalers

Pharmacies

Hospitals

Clinics

Uro-Oncology

Gene Therapy

Sales Achievement

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free